Xia & He Publishing Inc. Nov 11 2025 Background and aims Metabolic dysfunction-associated steatotic liver disease (MASLD) represents an escalating healthcare burden across the Middle East and North Africa (MENA) region; however, system-level preparedness remains largely undefined. This study aimed to assess existing models of care, clinical infrastructure, policy frameworks, and provider perspectives across 17 MENA countries. Methods A cross-sectional, mixed-methods survey was distributed to